Search Count: 8
 |
Crystal Structure Of Human Carbonic Anhydrase Ii In Complex With The 4-(5-(Chloromethyl)-1,3-Selenazol-2-Yl)Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.31 Å Release Date: 2019-07-17 Classification: LYASE Ligands: ZN, FMH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-07-17
Ligands: ZN, FMH
 |
Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target The Tumor-Associated Carbonic Anhydrase Isoforms Ix And Xii And Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-11-28 Classification: LYASE/LYASE inhibitor Ligands: ZN, J3V |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-11-28
Ligands: ZN, J3V
 |
Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target The Tumor-Associated Carbonic Anhydrase Isoforms Ix And Xii And Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2018-11-28 Classification: LYASE/LYAS INHIBITOR Ligands: ZN, J4D |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-11-28
Ligands: ZN, J4D
 |
Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target The Tumor-Associated Carbonic Anhydrase Isoforms Ix And Xii And Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-11-28 Classification: LYASE/LYASE INHIBITOR Ligands: ZN, J3V |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-11-28
Ligands: ZN, J3V
 |
Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target The Tumor-Associated Carbonic Anhydrase Isoforms Ix And Xii And Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2018-11-28 Classification: LYASE/LYASE inhibitor Ligands: ZN, J3V |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-11-28
Ligands: ZN, J3V
 |
Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target The Tumor-Associated Carbonic Anhydrase Isoforms Ix And Xii And Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2018-11-28 Classification: LYASE/LYASE inhibitor Ligands: ZN, J4D |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-11-28
Ligands: ZN, J4D
 |
Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target The Tumor-Associated Carbonic Anhydrase Isoforms Ix And Xii And Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2018-11-28 Classification: LYASE/LYASE inhibitor Ligands: ZN, J6V |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-11-28
Ligands: ZN, J6V
 |
Design, Synthesis, X-Ray And Biological Activities Of Selenides Bearing The Benzenesulfonamide Moiety As New Class Of Agents For Prevention Of Diabetic Cerebrovascular Pathology
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.43 Å Release Date: 2018-05-23 Classification: LYASE/LYASE INHIBITOR Ligands: ZN, EZ1, GOL, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-23
Ligands: ZN, EZ1, GOL, SO4